KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
KKR Takes Strategic Stake in Medical Supplier Henry Schein
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...
Hold Rating Maintained for Henry Schein Amid Strategic Investment by KKR and Soft Operational Performance
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
HME News1d
Henry Schein receives funding
Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal
Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...